Immunotherapy represents a promising option for treatment of hepatocellular carcinoma (HCC) in cirrhotic patients but its efficacy is currently inconsistent and unpredictable. | Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma A rationale for combining selective internal radiation therapy SIRT and immunotherapy